Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Developing a Low-Cost Hepatitis C Test for Low-Income Countries
Clinical Breakthroughs

Developing a Low-Cost Hepatitis C Test for Low-Income Countries

By Nora DunneNov 12, 2014
Share
Facebook Twitter Email
Robert Murphy, MD, ’81, ’84 GME, director of the Center for Global Health and John Philip Phair Professor of Infectious Diseases, will collaborate with the McCormick School of Engineering on this project. 

 

Robert Murphy, MD, ’81, ’84 GME, director of the Center for Global Health and John Philip Phair Professor of Infectious Diseases has been awarded funding to develop low-cost on-site tests to detect and monitor hepatitis C for patients in sub-Saharan Africa.

The five-year, $3 million project, supported by a grant from the National Cancer Institute’s (NCI) Center for Global Health (CGH), aims to identify patients at risk for developing hepatocellular carcinoma, a common and deadly type of liver cancer frequently caused by chronic hepatitis B or C infection.

More than 80 percent of the world’s cases of hepatocellular carcinoma occur in sub-Saharan Africa, where the cancer is not usually diagnosed until its late stages, when average life expectancy for patients is just one to three months.

“The new hepatitis C tests will identify infected people, who will then be offered treatment and screened for cancer,” said Dr. Murphy. “We hope to catch the cancer at an earlier stage and provide treatment with better outcomes.”

Nipping hepatitis C in the bud could prevent the liver cancer from forming in the first place. The virus is curable, but it’s difficult to diagnose in Africa. Many patients don’t have visible symptoms until it has already started to damage the liver, and the vast majority of people at risk for it don’t have access to existing diagnostic blood tests.

“Right now, the tests for viral hepatitis are sent to central referral laboratories that are relatively expensive and not available to most in Africa,” said Dr. Murphy. “Our easy-to-use, point-of-care tests could be done anywhere.”

In the first two years of project funding, Dr. Murphy and his collaborators at the McCormick School of Engineering will build testing platforms designed for use in low-resource countries. One test will detect the hepatitis C antigen to diagnose the disease. A second test will determine when to start therapy and monitor the viral response to treatment.

In the final three years of funding, the scientists will put the tests to practice in laboratory and clinical studies at the Jos University Teaching Hospital in Jos, Nigeria.

The project team includes Sally McFall, PhD,  and Robert Elghanian, PhD, both of McCormick’s Biomedical Engineering department;  Kara Palamountain, MBA, from the Kellogg School of Management; Claudia Hawkins, MD, ’06 GME, assistant professor in Medicine-Infectious Diseases; Maxwell Akanbi, ‘11 MSCI, Oche Agbaji and Edith Okeke from Jos; and Lewis Roberts, PhD, from the Mayo Clinic.

This work is supported by NCI CGH grant UH2 CA189965.

Global Health Patient Care Public Health Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.